Picton Mahoney Asset Management’s bluebird bio BLUE Stock Holding History

Picton Mahoney Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,220	Closed	-$16K	–	986
2025 Q1	$16K	Buy	+3,220	New	+$19.4K	﹤0.01%	603
2024 Q3	–	Sell	-161	Closed	-$3K	–	858
2024 Q2	$3K	Buy	+161	New	+$3.23K	﹤0.01%	547
2015 Q4	–	Sell	-124	Closed	-$137K	–	307
2015 Q3	$137K	Hold	124	–	–	0.01%	206
2015 Q2	$269K	Hold	124	–	–	0.01%	199
2015 Q1	$193K	Buy	+124	New	+$164K	0.01%	197
2013 Q4	–	Sell	-2,254	Closed	-$787K	–	340
2013 Q3	$787K	Buy	+2,254	New	+$837K	0.05%	191

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Picton Mahoney Asset Management's BLUE Position: Q2 2025 in Review

Picton Mahoney Asset Management sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 3,220 shares — an estimated $16K sold.

Picton Mahoney Asset Management first reported a position in BLUE in Q3 2013 and held it in 6 quarters. The position peaked at $787K in Q3 2013. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Picton Mahoney Asset Management reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Picton Mahoney Asset Management sold 3,220 bluebird bio shares in Q2 2025, an estimated $16K.
Picton Mahoney Asset Management first reported a position in bluebird bio in Q3 2013 and held it in 6 quarters.
Picton Mahoney Asset Management's bluebird bio position peaked at $787K in Q3 2013.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.